# A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI

> **NCT04023266** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 44 (actual)

## Conditions studied

- STEMI

## Interventions

- **DRUG:** Intravenous N-Acetylcysteine

## Key facts

- **NCT ID:** NCT04023266
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-20
- **Primary completion:** 2020-11-15
- **Final completion:** 2022-01-01
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04023266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04023266, "A Pilot Randomized Controlled Trial of Intravenous N-acetyl Cysteine in STEMI". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04023266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*